NZ595602A - Anti-cancer drugs, and uses relating for malignant melanoma and other cancers - Google Patents
Anti-cancer drugs, and uses relating for malignant melanoma and other cancersInfo
- Publication number
- NZ595602A NZ595602A NZ595602A NZ59560210A NZ595602A NZ 595602 A NZ595602 A NZ 595602A NZ 595602 A NZ595602 A NZ 595602A NZ 59560210 A NZ59560210 A NZ 59560210A NZ 595602 A NZ595602 A NZ 595602A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cancers
- malignant melanoma
- cancer drugs
- uses relating
- dimethylamino
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229940041181 antineoplastic drug Drugs 0.000 title 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 title 1
- 201000001441 melanoma Diseases 0.000 title 1
- CRUSSEBHSSZTHD-UHFFFAOYSA-N 4-(dimethylaminodiazenyl)-5-methylselenophene-2-carboxamide Chemical compound CN(C)N=NC=1C=C(C(N)=O)[se]C=1C CRUSSEBHSSZTHD-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- ZOXOSXWQXKBXTI-UHFFFAOYSA-N selenophene-2-carbonitrile Chemical compound N#CC1=CC=C[se]1 ZOXOSXWQXKBXTI-UHFFFAOYSA-N 0.000 abstract 1
- 150000005082 selenophenes Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/04—1,2,3-Triazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains three hetero rings
- C07D517/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN959CH2009 | 2009-04-27 | ||
| PCT/IN2010/000262 WO2010125575A1 (en) | 2009-04-27 | 2010-04-26 | Anti-cancer drugs, and uses relating for malignant melanoma and other cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595602A true NZ595602A (en) | 2013-05-31 |
Family
ID=42992332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595602A NZ595602A (en) | 2009-04-27 | 2010-04-26 | Anti-cancer drugs, and uses relating for malignant melanoma and other cancers |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8143237B2 (enExample) |
| EP (1) | EP2424351B1 (enExample) |
| JP (1) | JP5571168B2 (enExample) |
| KR (1) | KR20120006554A (enExample) |
| CN (1) | CN102438449B (enExample) |
| AU (1) | AU2010243213B2 (enExample) |
| BR (1) | BRPI1006651A2 (enExample) |
| CA (1) | CA2759519A1 (enExample) |
| IL (1) | IL215789A0 (enExample) |
| NZ (1) | NZ595602A (enExample) |
| WO (1) | WO2010125575A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2640392B1 (en) * | 2010-11-18 | 2015-01-07 | Kasina Laila Innova Pharmaceuticals Private Ltd. | Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof |
| US9090633B2 (en) | 2010-11-18 | 2015-07-28 | Kasina Laila Innova Pharmaceuticals Private Limited | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof |
| AU2011340063B2 (en) * | 2010-12-09 | 2016-03-24 | Kasina Laila Innova Pharmaceuticals Private Limited | Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof |
| WO2012176212A1 (en) | 2011-06-20 | 2012-12-27 | V.B. Medicare Pvt. Ltd. | Carrier based nanogel formulation for skin targeting. |
| EP2762472B1 (en) * | 2011-09-28 | 2017-05-24 | Industry-Academia Cooperation Group of Sejong University | Selenophene-fused aromatic compound and manufacturing method thereof |
| KR101418776B1 (ko) | 2011-09-28 | 2014-07-14 | 사회복지법인 삼성생명공익재단 | 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법 |
| WO2014012000A2 (en) | 2012-07-12 | 2014-01-16 | Euclises Pharmaceuticals, Inc. | No-releasing guanidine-coxib anti-cancer agents |
| WO2014012074A2 (en) | 2012-07-12 | 2014-01-16 | Euclises Pharmaceuticals, Inc. | No-releasing nonoate (nitrogen-bound) sulfonamide-linked-coxib anti-cancer agents |
| WO2014018888A1 (en) | 2012-07-26 | 2014-01-30 | Confluence Life Sciences Inc. | 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as tak1 inhibitors in disease treatment |
| US20150353542A1 (en) | 2013-01-14 | 2015-12-10 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| AU2016209046A1 (en) | 2015-01-23 | 2017-07-20 | Aclaris Therapeutics, Inc. | Heterocyclic ITK inhibitors for treating inflammation and cancer |
| CN108129475A (zh) * | 2018-02-08 | 2018-06-08 | 中南大学湘雅三医院 | 一种生物光敏剂及其制备方法和应用 |
| KR102648781B1 (ko) | 2021-11-09 | 2024-03-19 | 국립공주대학교 산학협력단 | 항암 활성을 갖는 인데노피라졸론 유도체 화합물, 그의 제조방법 및 그의 용도 |
| CN121712769A (zh) * | 2023-06-29 | 2026-03-20 | 艾健科学股份有限公司 | 新型硒吩衍生物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6620804B2 (en) * | 1996-06-03 | 2003-09-16 | Purdue Research Foundation | Selenophene anti-tumor agents |
| ATE247955T1 (de) * | 1996-06-03 | 2003-09-15 | Purdue Research Foundation | Selenophen-antitumormittel |
| US20100183726A1 (en) | 2006-08-02 | 2010-07-22 | Robert Nicolosi | Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| BRPI0913485A2 (pt) * | 2008-09-15 | 2016-06-07 | Kasina Laila Innova Pharmaceuticals Private Ltd | medicamentos anticâncer e usos relacionados para melanoma maligno metastático e outros cânceres. |
-
2010
- 2010-04-26 BR BRPI1006651-9A patent/BRPI1006651A2/pt not_active IP Right Cessation
- 2010-04-26 WO PCT/IN2010/000262 patent/WO2010125575A1/en not_active Ceased
- 2010-04-26 JP JP2012506649A patent/JP5571168B2/ja not_active Expired - Fee Related
- 2010-04-26 KR KR1020117027765A patent/KR20120006554A/ko not_active Ceased
- 2010-04-26 CN CN201080016304.7A patent/CN102438449B/zh not_active Expired - Fee Related
- 2010-04-26 US US12/767,647 patent/US8143237B2/en not_active Expired - Fee Related
- 2010-04-26 AU AU2010243213A patent/AU2010243213B2/en not_active Ceased
- 2010-04-26 NZ NZ595602A patent/NZ595602A/xx unknown
- 2010-04-26 CA CA2759519A patent/CA2759519A1/en not_active Abandoned
- 2010-04-26 EP EP10769410.1A patent/EP2424351B1/en not_active Not-in-force
-
2011
- 2011-10-23 IL IL215789A patent/IL215789A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2759519A1 (en) | 2010-11-04 |
| IL215789A0 (en) | 2012-01-31 |
| BRPI1006651A2 (pt) | 2015-08-25 |
| US20100272678A1 (en) | 2010-10-28 |
| CN102438449B (zh) | 2014-06-18 |
| JP2012525329A (ja) | 2012-10-22 |
| US8143237B2 (en) | 2012-03-27 |
| AU2010243213B2 (en) | 2014-09-11 |
| HK1166591A1 (en) | 2012-11-02 |
| EP2424351B1 (en) | 2015-10-21 |
| AU2010243213A1 (en) | 2011-10-27 |
| WO2010125575A1 (en) | 2010-11-04 |
| JP5571168B2 (ja) | 2014-08-13 |
| EP2424351A1 (en) | 2012-03-07 |
| EP2424351A4 (en) | 2013-04-03 |
| CN102438449A (zh) | 2012-05-02 |
| KR20120006554A (ko) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ577916A (en) | Cyclopamine analogs | |
| MX2014012695A (es) | Derivados de isoindolona. | |
| MY176944A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| GEP201706691B (en) | Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1 | |
| IL184872A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
| IL185063A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
| TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
| MX363609B (es) | Bencimidazoles triciclicos sustituidos como inhibidores de cinasas. | |
| TN2011000627A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
| TN2010000071A1 (en) | Fused imidazoles or cancer treatment | |
| TW200714604A (en) | Substituted heterocycles and the uses thereof | |
| NZ594186A (en) | Indole derivatives as anticancer agents | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| PH12012500497A1 (en) | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs | |
| AU2011274192A8 (en) | Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof | |
| NZ604480A (en) | Morpholino pyrimidines and their use in therapy | |
| MX2014002683A (es) | Derivados de benzonitrilo como inhibidores de cinasa. | |
| MX2013010898A (es) | Novedoso derivados de la pirimidina. | |
| PT2242743E (pt) | Derivados de aminopirazol | |
| MY155719A (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
| MX2020009397A (es) | Composiciones y metodos para inhibicion de la via jak. | |
| MX2012004264A (es) | Derivados de sulfoxidos para el tratamiento de tumores. | |
| IN2012DN03182A (enExample) | ||
| MX349550B (es) | 1,7-diazacarbazoles y metodos de uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 APR 2023 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20140318 Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 26 APR 2030 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20140318 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 APR 2020 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20140318 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 APR 2017 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20140318 |